Toronto, Ontario–(Newsfile Corp. – Le 6 novembre/November 2025) – The common shares of LIR Life Sciences Corp. (SKNY), previously listed as Blackbird Critical Metals Corp. (BBRD), have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

LIR Life Sciences Inc. is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the aim of improving accessibility and patient experience.

_________________________________

Les actions ordinaires de LIR Life Sciences Corp. (SKNY), précédemment cotées sous le nom de Blackbird Critical Metals Corp. (BBRD), ont été approuvées pour être inscrites à la CSE.

Les documents de cotation et de divulgation seront

See Full Page